305 related articles for article (PubMed ID: 17149756)
21. Negative regulation of beta-catenin/Tcf signaling by naringenin in AGS gastric cancer cell.
Lee JH; Park CH; Jung KC; Rhee HS; Yang CH
Biochem Biophys Res Commun; 2005 Sep; 335(3):771-6. PubMed ID: 16102728
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of Wnt-1 in thyrocytes enhances cellular growth but suppresses transcription of the thyroperoxidase gene via different signaling mechanisms.
Kim WB; Lewis CJ; McCall KD; Malgor R; Kohn AD; Moon RT; Kohn LD
J Endocrinol; 2007 Apr; 193(1):93-106. PubMed ID: 17400807
[TBL] [Abstract][Full Text] [Related]
23. [Adenovirus-mediated double suicide gene selectively kills breast cancer MCF-7 cells in vitro].
Kong H; Huang ZH; Li Q; Yang LC; Yu JL; Li Z
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):907-10. PubMed ID: 18583225
[TBL] [Abstract][Full Text] [Related]
24. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
Idogawa M; Sasaki Y; Suzuki H; Mita H; Imai K; Shinomura Y; Tokino T
Clin Cancer Res; 2009 Jun; 15(11):3725-32. PubMed ID: 19458054
[TBL] [Abstract][Full Text] [Related]
25. Docosahexaenoic acid induces proteasome-dependent degradation of beta-catenin, down-regulation of survivin and apoptosis in human colorectal cancer cells not expressing COX-2.
Calviello G; Resci F; Serini S; Piccioni E; Toesca A; Boninsegna A; Monego G; Ranelletti FO; Palozza P
Carcinogenesis; 2007 Jun; 28(6):1202-9. PubMed ID: 17183061
[TBL] [Abstract][Full Text] [Related]
26. Regulation of smooth muscle cell proliferation by beta-catenin/T-cell factor signaling involves modulation of cyclin D1 and p21 expression.
Quasnichka H; Slater SC; Beeching CA; Boehm M; Sala-Newby GB; George SJ
Circ Res; 2006 Dec; 99(12):1329-37. PubMed ID: 17122440
[TBL] [Abstract][Full Text] [Related]
27. Short hairpin RNA targeting beta-catenin suppresses cell proliferation and induces apoptosis in human gastric carcinoma cells.
Jiang H; Xia J; Kang J; Ding Y; Wu W
Scand J Gastroenterol; 2009; 44(12):1452-62. PubMed ID: 19958059
[TBL] [Abstract][Full Text] [Related]
28. Anticancer activity of Panax notoginseng extract 20(S)-25-OCH3-PPD: Targetting beta-catenin signalling.
Bi X; Zhao Y; Fang W; Yang W
Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1074-8. PubMed ID: 19413587
[TBL] [Abstract][Full Text] [Related]
29. Loss of beta-catenin expression in metastatic gastric cancer.
Ebert MP; Yu J; Hoffmann J; Rocco A; Röcken C; Kahmann S; Müller O; Korc M; Sung JJ; Malfertheiner P
J Clin Oncol; 2003 May; 21(9):1708-14. PubMed ID: 12721245
[TBL] [Abstract][Full Text] [Related]
30. A mammalian two-hybrid system for adenomatous polyposis coli-mutated colon cancer therapeutics.
Wakita K; Tetsu O; McCormick F
Cancer Res; 2001 Feb; 61(3):854-8. PubMed ID: 11221869
[TBL] [Abstract][Full Text] [Related]
31. STMN2 is a novel target of beta-catenin/TCF-mediated transcription in human hepatoma cells.
Lee HS; Lee DC; Park MH; Yang SJ; Lee JJ; Kim DM; Jang Y; Lee JH; Choi JY; Kang YK; Kim DI; Park KC; Kim SY; Yoo HS; Choi EJ; Yeom YI
Biochem Biophys Res Commun; 2006 Jul; 345(3):1059-67. PubMed ID: 16712787
[TBL] [Abstract][Full Text] [Related]
32. Frequent epigenetic inactivation of SFRP genes and constitutive activation of Wnt signaling in gastric cancer.
Nojima M; Suzuki H; Toyota M; Watanabe Y; Maruyama R; Sasaki S; Sasaki Y; Mita H; Nishikawa N; Yamaguchi K; Hirata K; Itoh F; Tokino T; Mori M; Imai K; Shinomura Y
Oncogene; 2007 Jul; 26(32):4699-713. PubMed ID: 17297461
[TBL] [Abstract][Full Text] [Related]
33. [Gene therapy targeting for carcinoma regulated by E2F-1 promoter].
Zhang XW; Meng ZH; Zhao JS; Zhang D; Xie YJ; Gao SH; Wang CY
Zhonghua Wai Ke Za Zhi; 2006 Dec; 44(23):1636-9. PubMed ID: 17359698
[TBL] [Abstract][Full Text] [Related]
34. Development of gastric tumors in Apc(Min/+) mice by the activation of the beta-catenin/Tcf signaling pathway.
Tomita H; Yamada Y; Oyama T; Hata K; Hirose Y; Hara A; Kunisada T; Sugiyama Y; Adachi Y; Linhart H; Mori H
Cancer Res; 2007 May; 67(9):4079-87. PubMed ID: 17483318
[TBL] [Abstract][Full Text] [Related]
35. Activation of the glutathione peroxidase 2 (GPx2) promoter by beta-catenin.
Kipp A; Banning A; Brigelius-Flohé R
Biol Chem; 2007 Oct; 388(10):1027-33. PubMed ID: 17937616
[TBL] [Abstract][Full Text] [Related]
36. Novel approach to abuse the hyperactive K-Ras pathway for adenoviral gene therapy of colorectal cancer.
Naumov I; Kazanov D; Lisiansky V; Starr A; Aroch I; Shapira S; Kraus S; Arber N
Exp Cell Res; 2012 Jan; 318(2):160-8. PubMed ID: 22020090
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of gastric cancer invasion and metastasis by PLA2G2A, a novel beta-catenin/TCF target gene.
Ganesan K; Ivanova T; Wu Y; Rajasegaran V; Wu J; Lee MH; Yu K; Rha SY; Chung HC; Ylstra B; Meijer G; Lian KO; Grabsch H; Tan P
Cancer Res; 2008 Jun; 68(11):4277-86. PubMed ID: 18519687
[TBL] [Abstract][Full Text] [Related]
38. Role of RUNX3 in bone morphogenetic protein signaling in colorectal cancer.
Lee CW; Ito K; Ito Y
Cancer Res; 2010 May; 70(10):4243-52. PubMed ID: 20442291
[TBL] [Abstract][Full Text] [Related]
39. Role of p53 up-regulated modulator of apoptosis and phosphorylated Akt in melanoma cell growth, apoptosis, and patient survival.
Karst AM; Dai DL; Cheng JQ; Li G
Cancer Res; 2006 Sep; 66(18):9221-6. PubMed ID: 16982766
[TBL] [Abstract][Full Text] [Related]
40. Physical and functional cooperation between AP-1 and beta-catenin for the regulation of TCF-dependent genes.
Toualbi K; Güller MC; Mauriz JL; Labalette C; Buendia MA; Mauviel A; Bernuau D
Oncogene; 2007 May; 26(24):3492-502. PubMed ID: 17146436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]